黑料官网

header-logo
黑料官网 Pharmacy School Logo White Medical School
Carolyn Oxenics, PharmD, BCPS, BCOP

Carolyn Oxencis, PharmD, BCPS, BCOP

Clinical Associate Professor, Department of Clinical Sciences

Locations

  • 黑料官网 Pharmacy School
    HRC H2600

Contact Information

Education

PharmD, University of Iowa College of Pharmacy, Iowa City, IA
BA, Journalism and Mass Communication, University of Iowa College of Liberal Arts, Iowa City, IA
Post Graduate Year One (PGY-1) Pharmacy Practice Residency, Froedtert Hospital

Certifications

Board Certified Oncology Pharmacist (BCOP), Board of Pharmacy Specialties
Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmacy Specialties
Collaborative Institutional Training Initiative (CITI) Certification, 黑料官网
Advanced Cardiac Life Support, American Heart Association
Immunization Certification, American Pharmacists Association

Biography

Carolyn Oxencis, PharmD, BCPS, BCOP, joined the 黑料官网 Pharmacy School in October 2016. Dr. Oxencis is a Hematology/Oncology Clinical Pharmacist at the Froedtert & the 黑料官网 Clinical Cancer Center. She received her Doctor of Pharmacy degree from the University of Iowa in May 2005, and completed a PGY1 Pharmacy Practice Residency at Froedtert and the 黑料官网 in June 2006. Dr. Oxencis spent the first 8 years of her career practicing in critical care, and transitioned into the field of oncology in 2012. She became a Board Certified Pharmacotherapy Specialist in 2010 and a Board Certified Oncology Pharmacist in 2015. Her role at the Pharmacy School includes developing the curriculum for the Hematology/Oncology Integrated Sequence course, and precepting pharmacy students during experiential rotations within the oncology service line at Froedtert Hospital.

Research Areas of Interest

  • Biomarkers, Tumor
  • Cancer Pain
  • Genetic Therapy
  • Health Literacy
  • Medical Oncology
  • Patient Reported Outcome Measures
  • Pharmacogenetics
  • Quality of Life
  • Theranostic Nanomedicine

Research Experience

  • Breast Neoplasms
  • Colonic Neoplasms
  • Pancreatic Neoplasms
  • Pharmacogenetics
  • Pharmacogenomic Testing
  • Rare Diseases

Clinical Expertise

  • Disease Management
  • Drug Therapy
  • Genetic Counseling
  • Pharmacogenetics
  • Pharmacogenomic Testing
  • Precision Medicine

Research Interests

  • Pharmacogenomics and precision medicine
  • Direct oral anticoagulant use in cancer patients
  • Cardiotoxicity of anticancer therapy
  • Transitions of care

Publications

  • (Moore C, Bourque MS, Halman A, Agúndez JAG, Prows CA, Hikino K, Schwab M, Oxencis CJ, Chauhan D, Diekstra MHM, Long SE, Bell GC, Gaedigk A, Whirl-Carrillo M, Klein TE, Caudle KE, Conyers R.) Clin Pharmacol Ther. 2026 Apr 14 PMID: 41979467 SCOPUS ID: 2-s2.0-105035723652 04/14/2026

  • (Grahl J, Mills M, Singh A, Oxencis C, Mohr A, Mancuso T, Teng BQ, Bajorunaite R, Carver T, Peppard WJ.) Hosp Pharm. 2025 May 20;60(6):00185787251339360 PMID: 40406364 PMCID: PMC12092407 SCOPUS ID: 2-s2.0-105005872042 05/23/2025

  • (Moore DC, Digiantonio N, Oxencis CJ, Taucher KD.) Am J Health Syst Pharm. 2024 Jul 08;81(14):574-582 PMID: 38394329 SCOPUS ID: 2-s2.0-85194354207 02/23/2024

  • (Moore DC, Oxencis CJ, Shank BR.) Am J Health Syst Pharm. 2022 Jul 08;79(14):1137-1145 PMID: 35333922 SCOPUS ID: 2-s2.0-85134360892 03/26/2022

  • (Haidar CE, Petry N, Oxencis C, Douglas JS, Hoffman JM.) Am J Health Syst Pharm. 2022 Apr 01;79(8):704-707 PMID: 34487145 SCOPUS ID: 2-s2.0-85128161244 09/07/2021

  • (Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE.) J Am Pharm Assoc (2003). 2022;62(4):1321-1328.e3 PMID: 35393248 SCOPUS ID: 2-s2.0-85127492109 04/09/2022

  • (Brown SA, Beavers C, Kamaraju S, Mohan M, Fatunde O, Echefu G, Zaharova S, Wallace B, Oxencis C.) Drug Metabolism Handbook Concepts and Applications in Cancer Research. 1 January 2022:967-992 SCOPUS ID: 2-s2.0-85148796959 01/01/2022

  • (Chakrabarti S, Wintheiser G, Tella SH, Oxencis C, Mahipal A.) Pharmacol Ther. 2021 Aug;224:107823 PMID: 33667525 SCOPUS ID: 2-s2.0-85102047484 03/06/2021

  • (Weil E, Zook F, Oxencis C, Canadeo A, Urmanski A, Waggoner M, Eastwood D, Pasquini M, Hamadani M, Hari P.) Biol Blood Marrow Transplant. 2017 Jun;23(6):952-957 PMID: 28288949 SCOPUS ID: 2-s2.0-85017516033 03/16/2017

  • (Weil E, Oxencis C.) Support Care Cancer. 2015 Aug;23(8):2507-13 PMID: 25971214 SCOPUS ID: 2-s2.0-84933182775 05/15/2015

  • (Murphy EM, Oxencis CJ, Klauck JA, Meyer DA, Zimmerman JM.) Am J Health Syst Pharm. 2009 Dec 01;66(23):2126-31 PMID: 19923314 SCOPUS ID: 2-s2.0-73649116397 11/20/2009

Publications of from the

My goal as a clinical instructor is to help future pharmacists develop the skills necessary to take independent thinking and learning beyond the scope of the classroom, with exceptional patient care at the forefront of each learning experience. I embrace case-based teaching and active learning activities as they stimulate intellectual camaraderie and cooperative problem solving, and lay the groundwork for life-long collaborative interprofessional practice.

Carolyn Oxencis, PharmD, BCPS, BCOP

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.